These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6323519)

  • 21. Menopausal flushes: effect of pituitary gonadotropin desensitization by a potent luteinizing hormone- releasing factor agonist.
    Casper RF; Yen SS
    J Clin Endocrinol Metab; 1981 Nov; 53(5):1056-8. PubMed ID: 6793613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neither exogenous nor endogenous GnRH stimulation alters the bio/immuno ratio of serum LH in healthy women and in polycystic ovarian disease.
    Ding YQ; Anttila L; Ruutiainen K; Erkkola R; Irjala K; Huhtaniemi I
    Acta Obstet Gynecol Scand; 1991; 70(3):211-7. PubMed ID: 1927298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men.
    Snyder PJ; Reitano JF; Utiger RD
    J Clin Endocrinol Metab; 1975 Nov; 41(5):938-45. PubMed ID: 1102556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progestins increase endogenous opioid peptide activity in postmenopausal women.
    Casper RF; Alapin-Rubillovitz S
    J Clin Endocrinol Metab; 1985 Jan; 60(1):34-6. PubMed ID: 3155455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE; Frager M; Case GD; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men.
    Castro-Fernández C; Olivares A; Söderlund D; López-Alvarenga JC; Zambrano E; Veldhuis JD; Ulloa-Aguirre A; Méndez JP
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4603-10. PubMed ID: 11134115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist.
    DeFazio J; Meldrum DR; Laufer L; Vale W; Rivier J; Lu JK; Judd HL
    J Clin Endocrinol Metab; 1983 Mar; 56(3):445-8. PubMed ID: 6401756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum luteinizing hormone (LH) biological activity in castrated patients with cancer of the prostate receiving a pure antiandrogen and in estrogen-pretreated patients treated with an LH-releasing hormone agonist and antiandrogen.
    St Arnaud R; Lachance R; Dupont A; Labrie F
    J Clin Endocrinol Metab; 1986 Aug; 63(2):297-302. PubMed ID: 3522618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of the surgical menopause syndrome with depot medroxyprogesterone acetate and its objective evaluation testing the reaction of the anterior pituitary gland to stimulation with gonadotropin-releasing hormone].
    Boschitsch E; Gitsch E; Spona J
    Wien Klin Wochenschr; 1983 Oct; 95(20):718-24. PubMed ID: 6229096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impotence associated with low biological to immunological ratio of luteinizing hormone in a man with a pituitary stone.
    Plourde PV; Dufau M; Plourde N; Santen RJ
    J Clin Endocrinol Metab; 1985 Apr; 60(4):797-802. PubMed ID: 3882739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal effects of gonadotropin-releasing hormone (GnRH) agonist in the human male. III. Effects of long term combined treatment with GnRH agonist and androgen.
    Bhasin S; Heber D; Steiner BS; Handelsman DJ; Swerdloff RS
    J Clin Endocrinol Metab; 1985 May; 60(5):998-1003. PubMed ID: 3920237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of luteinizing hormone-releasing hormone (LRH) upon bioactive and immunoreactive serum LH in patients with Turner's syndrome before and after oestrogen treatment.
    Celani MF; Montanini V; Marrama P
    Acta Endocrinol (Copenh); 1985 Jul; 109(3):304-8. PubMed ID: 3895799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of estrogen on the growth hormone response to the alpha-adrenergic agonist clonidine in women with menopausal flushing.
    Tulandi T; Lal S; Guyda H
    J Clin Endocrinol Metab; 1987 Jul; 65(1):6-10. PubMed ID: 2884230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men.
    Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ
    J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen induces the release of luteinizing hormone-releasing hormone in normal cyclic women.
    Miyake A; Tasaka K; Sakumoto T; Kawamura Y; Aono T
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1100-2. PubMed ID: 6302124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relation of physiological changes to subjective symptoms in postmenopausal women with and without hot flushes.
    Mashchak CA; Kletzky OA; Artal R; Mishell DR
    Maturitas; 1984 Dec; 6(4):301-8. PubMed ID: 6533433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass.
    López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic hyperestrogenemia: lack of positive feedback action on gonadotropin-releasing hormone-induced luteinizing hormone release and dual site of negative feedback action.
    Richardson DW; Gordon K; Billiar RB; Little AB
    Endocrinology; 1992 Mar; 130(3):1090-6. PubMed ID: 1537275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women.
    Meldrum DR; Tsao Z; Monroe SE; Braunstein GD; Sladek J; Lu JK; Vale W; Rivier J; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1984 Apr; 58(4):755-7. PubMed ID: 6365947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
    Blum I; Vered Y; Lifshitz A; Harel D; Blum M; Nordenberg Y; Harsat A; Sulkes J; Gabbay U; Graff E
    Isr J Med Sci; 1996 Dec; 32(12):1158-62. PubMed ID: 9007144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.